The Peptide Directory

Not approved (research only)Growth hormone fragmentFat-loss research

HGH fragment 176-191

HGH fragment 176-191 is the C-terminal portion of growth hormone studied for lipolysis; its modified form AOD-9604 failed to show weight loss in human trials.

Last reviewed by The Peptide Directory Editorial Team

What is HGH fragment 176-191?

HGH fragment 176-191 is the C-terminal portion of growth hormone studied for lipolysis; its modified form AOD-9604 failed to show weight loss in human trials. HGH fragment 176-191 is not approved by the FDA for any use; products sold under this name are labeled for research use only, not for human consumption.

Key takeaways

  1. HGH fragment 176-191 is not approved by the FDA for any use; products sold under this name are labeled for research use only, not for human consumption.
  2. PubMed indexes 1 papers on HGH fragment 176-191 (0 tagged as clinical trials) as of October 19, 2026.
  3. 12 vendors in our directory listed HGH fragment 176-191 in their public catalog on October 19, 2026.

Structure

2D chemical structure of HGH fragment 176-191 (C80H127N23O24S2), as depicted by PubChem
Structure: PubChem CID 172966176 (C80H127N23O24S2, 1,859.1 g/mol). 2D depiction from NCBI PubChem, retrieved October 19, 2026.

Regulatory & access status

HGH fragment 176-191 is not approved by the FDA for any use; products sold under this name are labeled for research use only, not for human consumption.

Sellers that market unapproved peptides for human use can receive FDA warning letters; our vendor directory links any letter we found on fda.gov.

How much research exists on HGH fragment 176-191?

PubMed indexes 1 papers mentioning HGH fragment 176-191 in the title or abstract, 1 of them from the last five years and 0 tagged as clinical trials (search run October 19, 2026; repeat the search).

Most relevant recent papers

What the evidence does not show

  • Paper counts measure research attention, not whether HGH fragment 176-191 works or is safe.
  • No clinical trial in humans is tagged in PubMed under this name.
  • No FDA review of any "research use only" product's identity, purity, sterility or dose.

Research suppliers that list HGH fragment 176-191

12 vendors in our directory listed a product matching HGH fragment 176-191 in their public catalog on October 19, 2026. Listed alphabetically; a listing is not an endorsement. Research use only.

Prices per mg, where we could verify them, are on our price comparison.

HGH fragment 176-191 reconstitution math

Lab arithmetic only, not dosing guidance: use the peptide calculator to turn a vial size and diluent volume into a concentration.

HGH fragment 176-191 FAQ

Is HGH fragment 176-191 FDA-approved?

HGH fragment 176-191 is not approved by the FDA for any use; products sold under this name are labeled for research use only, not for human consumption.

Is HGH fragment 176-191 safe?

There are no published human safety trials of HGH fragment 176-191 that we could find. Products sold as "research use only" have no FDA review of purity, sterility or dose, and are not for human use.

How much research is there on HGH fragment 176-191?

PubMed indexes 1 papers on HGH fragment 176-191 (0 tagged as clinical trials) as of October 19, 2026.

Who sells HGH fragment 176-191?

BioGenix Peptides, Biotech Peptides, Core Peptides, Eros Peptides, Extreme Peptides, Ion Peptide and 6 more listed it on their public catalogs when we checked; a listing is not an endorsement.

Related compounds

SemaglutideLiraglutideFollistatin-315FollistatinTirzepatideGHRHAICARGHRP-6All weight loss & glp-1All growth hormone & ghrh